A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management

Clinical trial NCT05062902 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05062902
Sponsor: HillMed Inc.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Interstitial Cystitis Chronic Pain Pelvic Floor; Relaxation Pelvic Floor Disorders

Start date: 2025-09-15
Primary completion: 2027-08-15
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.